Get the Stockscreener App
1.92
1.05%
0.02
Durect Corp stock is traded at $1.92, with a volume of 416.98K.
It is up +1.05% in the last 24 hours and up +249.09% over the past month.
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
See More
Previous Close:
$1.90
Open:
$1.92
24h Volume:
416.98K
Relative Volume:
0.43
Market Cap:
$59.62M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
-3.1475
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
+0.52%
1M Performance:
+249.09%
6M Performance:
+140.30%
1Y Performance:
+41.18%
1-Day Range:
$1.90
$1.935
1-Week Range:
$1.86
$1.935
52-Week Range:
$0.4801
$2.64
Durect Corp Stock (DRRX) Company Profile
Name
Durect Corp
Sector
Phone
(408) 777-1417
Address
10240 BUBB ROAD, CUPERTINO, CA
Compare DRRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRRX
Durect Corp
|
1.92 | 59.00M | 8.59M | -17.07M | -21.90M | -0.61 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-30-20 | Initiated | Chardan Capital Markets | Buy |
| Oct-12-20 | Initiated | ROTH Capital | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jan-31-20 | Initiated | B. Riley FBR | Buy |
| Nov-18-19 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-18 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-20-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-20-17 | Reiterated | Laidlaw | Buy |
| Oct-20-17 | Downgrade | Stifel | Buy → Hold |
| Jul-12-17 | Upgrade | Stifel | Hold → Buy |
| Feb-28-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-16 | Initiated | Rodman & Renshaw | Buy |
| May-01-15 | Reiterated | Cantor Fitzgerald | Buy |
| May-01-15 | Reiterated | Stifel | Buy |
| Mar-25-13 | Initiated | Stifel | Buy |
| Nov-01-12 | Downgrade | C.K. Cooper | Buy → Hold |
| Aug-17-12 | Initiated | C.K. Cooper | Buy |
| Jun-23-09 | Initiated | Caris & Company | Buy |
| Mar-26-09 | Initiated | Wedbush Morgan | Hold |
View All
Durect Corp Stock (DRRX) Latest News
Is DURECT Corporation stock reversal real or fake2025 Performance Recap & Weekly High Momentum Picks - Newser
Published on: 2025-08-20 01:19:24 - Newser
Using R and stats models for DURECT Corporation forecastingTrade Performance Summary & High Win Rate Trade Alerts - Newser
Will DURECT Corporation continue its uptrend2025 Volatility Report & Weekly High Momentum Picks - Newser
Can swing trading help recover from DURECT Corporation losses2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Using data tools to time your DURECT Corporation exitEarnings Summary Report & Breakout Confirmation Alerts - Newser
Sentiment analysis tools applied to DURECT CorporationPortfolio Update Summary & Smart Investment Allocation Insights - Newser
DURECT (NASDAQ:DRRX) Stock Price Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
What does recent volatility data suggest for DURECT CorporationTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Reversal indicators forming on DURECT Corporation stock2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
Technical signs of recovery in DURECT CorporationPortfolio Return Report & Community Trade Idea Sharing - Newser
Market reaction to DURECT Corporation’s recent newsJuly 2025 Sector Moves & Free Community Supported Trade Ideas - Newser
Signal strength of DURECT Corporation stock in tech scannersMarket Performance Summary & Proven Capital Preservation Tips - Newser
Chart based exit strategy for DURECT CorporationDip Buying & Low Drawdown Trading Techniques - Newser
When is the best time to exit DURECT CorporationPortfolio Value Summary & Accurate Buy Signal Alerts - Newser
Durect 2025 Q2 Earnings Net Loss Narrows by 38.8% - AInvest
DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - sundaytimes.kr
Durect: Q2 Earnings Snapshot - Connecticut Post
Published on: 2025-08-12 20:28:09 - Newser
Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
DRRX 8-K: Announces Q2 2025 Financial Results Under Regulation FD - Stock Titan
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser
How is DRRX performing? - AInvest
Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser
DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey
Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest
Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser
What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News
Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress
What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser
Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser
Durect Corp Stock (DRRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):